Literature DB >> 29771745

National Institute on Drug Abuse International Program: improving opioid use disorder treatment through international research training.

Steven W Gust1, Judy McCormally2.   

Abstract

PURPOSE OF REVIEW: For more than 25 years, the National Institute on Drug Abuse (NIDA) has supported research-training programs, establishing a global research network and expanding the knowledge base on substance use disorders. International research to inform approaches to opioid addiction is particularly important and relevant to the United States, where opioid misuse, addiction, and overdose constitute an emerging public health crisis. This article summarizes the NIDA International Program and illustrates its impact by reviewing recent articles about treatment approaches for opioid use disorders (OUD). RECENT
FINDINGS: Studies in several countries have demonstrated the effectiveness of physician office-based opioid substitution therapies. Other research has demonstrated the effectiveness of different formulations and doses of the opioid antagonist naltrexone, as well as different approaches to providing naloxone to treat opioid overdose. Continuing research into implementation of evidence-based treatment in international settings with limited resources is applicable to US regions that face similar structural, legal, and fiscal constraints.
SUMMARY: The current review describes international research on OUD treatment and opioid overdose, most coauthored by former NIDA fellows. The findings from outside the United States have important implications for best practices domestically and in other countries that are experiencing increases in OUD prevalence and related overdose deaths.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29771745      PMCID: PMC6050030          DOI: 10.1097/YCO.0000000000000426

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  31 in total

1.  Policy progress for physician treatment of opiate addiction.

Authors:  Joseph O Merrill
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

2.  Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine.

Authors:  Ruthanne Marcus; Iuliia Makarenko; Alyona Mazhnaya; Alexei Zelenev; Maxim Polonsky; Lynn Madden; Sergii Filippovych; Sergii Dvoriak; Sandra A Springer; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2017-08-05       Impact factor: 4.492

3.  Primary Care - A key route for distribution of naloxone in the community.

Authors:  Jan Klimas; Helen Tobin; Mairead Egan; Barry Tomas; Gerard Bury
Journal:  Int J Drug Policy       Date:  2016-10-25

4.  Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.

Authors:  Iuliia Makarenko; Alyona Mazhnaya; Ruthanne Marcus; Martha J Bojko; Lynn Madden; Sergii Filippovich; Sergii Dvoriak; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2017-06-16

5.  Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision.

Authors:  Tomás Barry; Jan Klimas; Helen Tobin; Mairead Egan; Gerard Bury
Journal:  Br J Gen Pract       Date:  2017-02-28       Impact factor: 5.386

Review 6.  Update on Barriers to Pharmacotherapy for Opioid Use Disorders.

Authors:  Anjalee Sharma; Sharon M Kelly; Shannon Gwin Mitchell; Jan Gryczynski; Kevin E O'Grady; Robert P Schwartz
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

7.  Psychological Distress Among Methadone Maintenance Patients in Vietnamese Mountainous Areas.

Authors:  Long Hoang Nguyen; Bach Xuan Tran; Huong Lan Thi Nguyen; Cuong Tat Nguyen; Canh Dinh Hoang; Hai Quan Le; Hung Van Nguyen; Huong Thi Le; Tho Dinh Tran; Carl A Latkin; Thuc Minh Thi Vu
Journal:  AIDS Behav       Date:  2017-11

8.  Dose, Plasma Level, and Treatment Outcome Among Methadone Patients in Shanghai, China.

Authors:  Haifeng Jiang; Maureen Hillhouse; Jiang Du; Shujun Pan; Ang Alfonso; Jun Wang; Zhirong Zhou; Weijun Yuan; Walter Ling; Min Zhao
Journal:  Neurosci Bull       Date:  2016-09-10       Impact factor: 5.203

9.  A Smartphone Application Supporting Recovery from Heroin Addiction: Perspectives of Patients and Providers in China, Taiwan, and the USA.

Authors:  Marya Schulte; Di Liang; Fei Wu; Yu-Ching Lan; Wening Tsay; Jiang Du; Min Zhao; Xu Li; Yih-Ing Hser
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-04       Impact factor: 4.147

10.  Adherence to methadone maintenance treatment and associated factors among patients in Vietnamese mountainside areas.

Authors:  Long Hoang Nguyen; Huong Thu Thi Nguyen; Huong Lan Thi Nguyen; Bach Xuan Tran; Carl A Latkin
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.